Cannabis and Tobacco Co-Use Is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis (IMAGE)

Elsevier

Cannabis and Tobacco Co-Use Is Associated with Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis

Caption

A study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging shows that among people at clinical high risk for psychosis, cannabis and tobacco co-use was associated with lower cognitive performance compared to healthy controls. This image shows a comparison between neurocognitive performance on the MATRICS Consensus Cognitive Battery (MCCB) across substance use groups. All individuals at risk for psychosis, except the Cannabis group, had lower global cognitive performance than healthy controls.

Credit

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging / Heather Burrell Ward, MD

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.